Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SANTA MONICA, Calif., Feb. 8, 2007 (PRIME NEWSWIRE) -- Genesis Bioventures, Inc. (OTCBB:GBIW), a biomedical development corporation focusing on the development and commercialization of novel...
-
LOS ANGELES, Dec. 7, 2006 (PRIME NEWSWIRE) -- Genesis Bioventures, Inc. (OTCBB:GBIW) today announced that its President and CEO, Mr. Douglas C. Lane, delivered four presentations on Genesis...
-
NEW YORK, Oct. 10, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) announced today that Prion Developmental Laboratories ("PDL"), its minority owned subsidiary company, entered into a...
-
LOS ANGELES, Oct. 5, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (OTCBB:GBIW), announced that Douglas Lane, GBIW's President, CEO, and Chairman, was featured in an exclusive interview with...
-
NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that its President and CEO, Mr. Douglas C. Lane, will present the newly restructured Genesis...
-
NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that the Company and Prion Developmental Laboratories ("PDL") mutually agreed on August 30, 2006 to...